Concurrent FSGS and Hodgkin's lymphoma: case report and literature review on the link between nephrotic glomerulopathies and hematological malignancies

• Published in: Clinical and experimental nephrology Vol. 10; no. 4; pp. 284 - 289
• Main Authors: Mallouk, Abdalla, Pham, Phuong-Thu T, Pham, Phuong-Chi T
• Format: Journal Article
• Language: English
• Published: Japan Springer Nature B.V 01.12.2006
• Subjects: Adult; Glomerulonephritis - etiology; Glomerulosclerosis, Focal Segmental - complications; Hodgkin Disease - complications; Humans; Leukemia - complications; Lymphoma - complications; Male; Nephrotic Syndrome - etiology
• ISSN: 1342-1751; 1437-7799
• DOI: 10.1007/s10157-006-0437-4

The link between the nephrotic syndrome (NS) and malignancy was first described in 1922. In solid tumors, the NS is most often due to membranous glomerulonephropathy, whereas in common hematological malignancies, minimal-change disease predominates. Focal segmental glomerulosclerosis (FSGS) is among the least frequently reported renal lesion associated with malignancy. We report a case of the simultaneous diagnoses of FSGS and Hodgkin's lymphoma, and review the literature on various nephrotic glomerulonephropathies associated with common leukemia and lymphoma. Although nephrotic glomerulonephropathies rarely occur in association with acute leukemia, they have often been described in chronic lymphocytic leukemia (CLL). Membranoproliferative glomerulonephropathy and membranous glomerulonephropathy are the most common lesions observed in CLL. Nephrotic glomerulonephropathies have also been well documented among patients with lymphomas, in particular, Hodgkin's lymphoma. While minimal-change disease is most commonly found in association with Hodgkin's lymphoma, more diverse and complex renal lesions are associated with non-Hodgkin's lymphoma. FSGS remains a rare association with hematological malignancies. Nephrotic glomerulonephropathies are not only linked to solid-organ tumors, but also to hematological malignancies. A thorough evaluation, including a physical examination for lymphadenopathy and organomegaly, as well as a hematological evaluation, must be performed in all patients presenting with nephrotic glomerulonephropathies.